Sydney, Australia – Virtus Health (“Virtus”, ASX:VRT), Australia’s largest fertility services provider, has agreed terms to acquire the business and certain assets of Independent Diagnostic Services (IDS), a general category pathology laboratory based in Sydney, Australia, as part of its strategy to expand and strengthen its diagnostics services. Completion of the acquisition is expected to take place during September 2015 subject to regulatory approval.
Pro-forma net profit after tax (NPAT) grew 17.2% on the previous year to $32 million, from $27.3 million; pro-forma revenue rose 6.7% on the previous year to $199.9 million, from $187.3 million. Actual (or statutory) revenue from ordinary activities increased 7.9% to $201.2 million from $186.6 million while statutory net profit attributable to the owners of Virtus Health Limited tripled to $30.9million, from $10.1 million.
In an Australian first, two families have delivered healthy babies on the same day (one in Melbourne, the other Sydney) conceived using karyomapping, a new pre-implantation genetic test based on the use of DNA fingerprinting to identify defective genes.
Sydney, Australia – Further to the announcement to ASX made on 24 December 2014, Virtus Health (“Virtus”, ASX: VRT), Australia’s largest IVF provider, announces that its 70% owned subsidiary, Sims IVF Clinic, Ireland’s largest IVF provider, has completed the acquisition of Irish fertility centre, the HARI clinic from the Rotunda Hospital in Dublin for €6 million.